4.5 Review

Silver Nanoparticles: Therapeutical Uses, Toxicity, and Safety Issues

期刊

JOURNAL OF PHARMACEUTICAL SCIENCES
卷 103, 期 7, 页码 1931-1944

出版社

ELSEVIER SCIENCE INC
DOI: 10.1002/jps.24001

关键词

nanotechnology; silver nanoparticles; therapeutics; antimicrobials; toxicity; drug delivery; coating; synthesis; biomaterials

资金

  1. Department of Science and Technology (DST)
  2. University Grants Commission (UGC), New Delhi
  3. Rajiv Gandhi Science and Technology Commission, Mumbai
  4. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp) [2010/51933-9, 2012/03731-3]
  5. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)
  6. Council of Scientific and Industrial Research, New Delhi

向作者/读者索取更多资源

The promises of nanotechnology have been realized to deliver the greatest scientific and technological advances in several areas. The biocidal activity of Metal nanoparticles in general and silver nanoparticles (AgNPs) depends on several morphological and physicochemical characteristics of the particles. Many of the interactions of the AgNPs with the human body are still poorly understood; consequently, the most desirable characteristics for the AgNPs are not yet well established. Therefore, the development of nanoparticles with well-controlled morphological and physicochemical features for application in human body is still an active area of interdisciplinary research. Effects of the development of technology of nanostructured compounds seem to be so large and comprehensive that probably it will impact on all fields of science and technology. However, mechanisms of safety control in application, utilization, responsiveness, and disposal accumulation still need to be further studied in-depth to ensure that the advances provided by nanotechnology are real and liable to provide solid and consistent progress. This review aims to discuss AgNPs applied in biomedicine and as promising field for insertion and development of new compounds related to medical and pharmacy technology. The review also addresses drug delivery, toxicity issues, and the safety rules concerning biomedical applications of silver nanoparticles. (c) 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 103:1931-1944, 2014

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据